Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antidepressant Drugs
1.2.3 SSRIs
1.2.4 SNRIs
1.2.5 Benzodiazepines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Major Depressive Disorder (MDD) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Major Depressive Disorder (MDD) Market Perspective (2018-2033)
2.2 Major Depressive Disorder (MDD) Growth Trends by Region
2.2.1 Global Major Depressive Disorder (MDD) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Major Depressive Disorder (MDD) Historic Market Size by Region (2018-2023)
2.2.3 Major Depressive Disorder (MDD) Forecasted Market Size by Region (2024-2033)
2.3 Major Depressive Disorder (MDD) Market Dynamics
2.3.1 Major Depressive Disorder (MDD) Industry Trends
2.3.2 Major Depressive Disorder (MDD) Market Drivers
2.3.3 Major Depressive Disorder (MDD) Market Challenges
2.3.4 Major Depressive Disorder (MDD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Major Depressive Disorder (MDD) Players by Revenue
3.1.1 Global Top Major Depressive Disorder (MDD) Players by Revenue (2018-2023)
3.1.2 Global Major Depressive Disorder (MDD) Revenue Market Share by Players (2018-2023)
3.2 Global Major Depressive Disorder (MDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Major Depressive Disorder (MDD) Revenue
3.4 Global Major Depressive Disorder (MDD) Market Concentration Ratio
3.4.1 Global Major Depressive Disorder (MDD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder (MDD) Revenue in 2022
3.5 Major Depressive Disorder (MDD) Key Players Head office and Area Served
3.6 Key Players Major Depressive Disorder (MDD) Product Solution and Service
3.7 Date of Enter into Major Depressive Disorder (MDD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Major Depressive Disorder (MDD) Breakdown Data by Type
4.1 Global Major Depressive Disorder (MDD) Historic Market Size by Type (2018-2023)
4.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2024-2033)
5 Major Depressive Disorder (MDD) Breakdown Data by Application
5.1 Global Major Depressive Disorder (MDD) Historic Market Size by Application (2018-2023)
5.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Major Depressive Disorder (MDD) Market Size (2018-2033)
6.2 North America Major Depressive Disorder (MDD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Major Depressive Disorder (MDD) Market Size by Country (2018-2023)
6.4 North America Major Depressive Disorder (MDD) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Major Depressive Disorder (MDD) Market Size (2018-2033)
7.2 Europe Major Depressive Disorder (MDD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Major Depressive Disorder (MDD) Market Size by Country (2018-2023)
7.4 Europe Major Depressive Disorder (MDD) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size (2018-2033)
8.2 Asia-Pacific Major Depressive Disorder (MDD) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Major Depressive Disorder (MDD) Market Size (2018-2033)
9.2 Latin America Major Depressive Disorder (MDD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Major Depressive Disorder (MDD) Market Size by Country (2018-2023)
9.4 Latin America Major Depressive Disorder (MDD) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size (2018-2033)
10.2 Middle East & Africa Major Depressive Disorder (MDD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Major Depressive Disorder (MDD) Introduction
11.1.4 Pfizer Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Major Depressive Disorder (MDD) Introduction
11.2.4 GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Major Depressive Disorder (MDD) Introduction
11.3.4 Merck Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.3.5 Merck Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Major Depressive Disorder (MDD) Introduction
11.4.4 AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 Eli Lily
11.5.1 Eli Lily Company Detail
11.5.2 Eli Lily Business Overview
11.5.3 Eli Lily Major Depressive Disorder (MDD) Introduction
11.5.4 Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.5.5 Eli Lily Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Major Depressive Disorder (MDD) Introduction
11.6.4 Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Forest Laboratories
11.7.1 Forest Laboratories Company Detail
11.7.2 Forest Laboratories Business Overview
11.7.3 Forest Laboratories Major Depressive Disorder (MDD) Introduction
11.7.4 Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.7.5 Forest Laboratories Recent Development
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Detail
11.8.2 Sanofi-Aventis Business Overview
11.8.3 Sanofi-Aventis Major Depressive Disorder (MDD) Introduction
11.8.4 Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.8.5 Sanofi-Aventis Recent Development
11.9 H. Lundbeck
11.9.1 H. Lundbeck Company Detail
11.9.2 H. Lundbeck Business Overview
11.9.3 H. Lundbeck Major Depressive Disorder (MDD) Introduction
11.9.4 H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.9.5 H. Lundbeck Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Detail
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Major Depressive Disorder (MDD) Introduction
11.10.4 Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2018-2023)
11.10.5 Bristol-Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antidepressant Drugs
Table 3. Key Players of SSRIs
Table 4. Key Players of SNRIs
Table 5. Key Players of Benzodiazepines
Table 6. Key Players of Others
Table 7. Global Major Depressive Disorder (MDD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Major Depressive Disorder (MDD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Major Depressive Disorder (MDD) Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Major Depressive Disorder (MDD) Market Share by Region (2018-2023)
Table 11. Global Major Depressive Disorder (MDD) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Major Depressive Disorder (MDD) Market Share by Region (2024-2033)
Table 13. Major Depressive Disorder (MDD) Market Trends
Table 14. Major Depressive Disorder (MDD) Market Drivers
Table 15. Major Depressive Disorder (MDD) Market Challenges
Table 16. Major Depressive Disorder (MDD) Market Restraints
Table 17. Global Major Depressive Disorder (MDD) Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Major Depressive Disorder (MDD) Market Share by Players (2018-2023)
Table 19. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder (MDD) as of 2022)
Table 20. Ranking of Global Top Major Depressive Disorder (MDD) Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Major Depressive Disorder (MDD) Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Major Depressive Disorder (MDD) Product Solution and Service
Table 24. Date of Enter into Major Depressive Disorder (MDD) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Major Depressive Disorder (MDD) Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2018-2023)
Table 28. Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2024-2033)
Table 30. Global Major Depressive Disorder (MDD) Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2018-2023)
Table 32. Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2024-2033)
Table 34. North America Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Major Depressive Disorder (MDD) Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Major Depressive Disorder (MDD) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Major Depressive Disorder (MDD) Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Major Depressive Disorder (MDD) Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Major Depressive Disorder (MDD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Major Depressive Disorder (MDD) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Major Depressive Disorder (MDD) Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2024-2033) & (US$ Million)
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Major Depressive Disorder (MDD) Product
Table 52. Pfizer Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. GlaxoSmithKline Company Detail
Table 55. GlaxoSmithKline Business Overview
Table 56. GlaxoSmithKline Major Depressive Disorder (MDD) Product
Table 57. GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 58. GlaxoSmithKline Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Major Depressive Disorder (MDD) Product
Table 62. Merck Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 63. Merck Recent Development
Table 64. AstraZeneca Company Detail
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Major Depressive Disorder (MDD) Product
Table 67. AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Eli Lily Company Detail
Table 70. Eli Lily Business Overview
Table 71. Eli Lily Major Depressive Disorder (MDD) Product
Table 72. Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 73. Eli Lily Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Major Depressive Disorder (MDD) Product
Table 77. Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Forest Laboratories Company Detail
Table 80. Forest Laboratories Business Overview
Table 81. Forest Laboratories Major Depressive Disorder (MDD) Product
Table 82. Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 83. Forest Laboratories Recent Development
Table 84. Sanofi-Aventis Company Detail
Table 85. Sanofi-Aventis Business Overview
Table 86. Sanofi-Aventis Major Depressive Disorder (MDD) Product
Table 87. Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 88. Sanofi-Aventis Recent Development
Table 89. H. Lundbeck Company Detail
Table 90. H. Lundbeck Business Overview
Table 91. H. Lundbeck Major Depressive Disorder (MDD) Product
Table 92. H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 93. H. Lundbeck Recent Development
Table 94. Bristol-Myers Squibb Company Detail
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Major Depressive Disorder (MDD) Product
Table 97. Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Major Depressive Disorder (MDD) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Major Depressive Disorder (MDD) Market Share by Type: 2022 VS 2033
Figure 3. Antidepressant Drugs Features
Figure 4. SSRIs Features
Figure 5. SNRIs Features
Figure 6. Benzodiazepines Features
Figure 7. Others Features
Figure 8. Global Major Depressive Disorder (MDD) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Major Depressive Disorder (MDD) Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Major Depressive Disorder (MDD) Report Years Considered
Figure 14. Global Major Depressive Disorder (MDD) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Major Depressive Disorder (MDD) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Major Depressive Disorder (MDD) Market Share by Region: 2022 VS 2033
Figure 17. Global Major Depressive Disorder (MDD) Market Share by Players in 2022
Figure 18. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder (MDD) as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Major Depressive Disorder (MDD) Revenue in 2022
Figure 20. North America Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Major Depressive Disorder (MDD) Market Share by Country (2018-2033)
Figure 22. United States Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Major Depressive Disorder (MDD) Market Share by Country (2018-2033)
Figure 26. Germany Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Region (2018-2033)
Figure 34. China Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Major Depressive Disorder (MDD) Market Share by Country (2018-2033)
Figure 42. Mexico Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Country (2018-2033)
Figure 46. Turkey Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Major Depressive Disorder (MDD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 52. Eli Lily Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 54. Forest Laboratories Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 55. Sanofi-Aventis Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 56. H. Lundbeck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed